Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Wong Mito Lab, |
RCV000714930 | SCV000845696 | benign | Combined oxidative phosphorylation defect type 14 | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000714930 | SCV001679700 | likely benign | Combined oxidative phosphorylation defect type 14 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003918155 | SCV004731344 | likely benign | FARS2-related disorder | 2019-05-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |